Three new cases of bullous pemphigoid during anti-PD-1 antibody therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Three new cases of bullous pemphigoid during anti-PD-1 antibody therapy

Published:2017-10-24 Issue:3 Volume:32 Page:e104-e106
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Le Naour S.¹,Peuvrel L.¹²³⁴,Saint-Jean M.¹²³⁴,Dreno B.¹²³⁴,Quereux G.¹²³⁴

Affiliation:

1. Department of Dermatology; Nantes University Hospital; Nantes France

2. INSERM U 1232; Nantes France

3. Immuno-Dermatology Laboratory; Nantes University Hospital; Nantes France

4. INSERM CIC 1413; Clinical Investigation Center; Nantes University Hospital; Nantes France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14579/fullpdf

Reference8 articles.

1. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA−4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015

2. Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group;Vaillant;Arch Dermatol,1998

3. Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD−1 and PD-L1;Naidoo;Cancer Immunol Res,2016

4. A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab;Carlos;Melanoma Res,2015

5. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD−1 antibody therapy: a report on bullous skin eruptions;Jour;J Cutan Pathol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer;JAMA Dermatology;2022-08-01

2. A Case of Systemic Severe Bullous Pemphigoid Caused by Long-Term Sintilimab Treatment for Renal Cell Carcinoma;Clinical, Cosmetic and Investigational Dermatology;2022-08

3. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab;Dermatologic Therapy;2022-03-15

4. Treatment‐resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors;Journal of the European Academy of Dermatology and Venereology;2021-05-13

5. Clinical, biological and histological characteristics of bullous pemphigoid associated with anti‐PD‐1/PD‐L1 therapy: A national retrospective study;Journal of the European Academy of Dermatology and Venereology;2021-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3